125 related articles for article (PubMed ID: 25778746)
21. Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide.
Lu J; Chew EH; Holmgren A
Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12288-93. PubMed ID: 17640917
[TBL] [Abstract][Full Text] [Related]
22. Inhibition and crosslinking of the selenoprotein thioredoxin reductase-1 by p-benzoquinone.
Shu N; Cheng Q; Arnér ESJ; Davies MJ
Redox Biol; 2020 Jan; 28():101335. PubMed ID: 31590044
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of thioredoxin and thioredoxin reductase by 4-hydroxy-2-nonenal in vitro and in vivo.
Fang J; Holmgren A
J Am Chem Soc; 2006 Feb; 128(6):1879-85. PubMed ID: 16464088
[TBL] [Abstract][Full Text] [Related]
24. Effects of selenite and chelating agents on mammalian thioredoxin reductase inhibited by mercury: implications for treatment of mercury poisoning.
Carvalho CM; Lu J; Zhang X; Arnér ES; Holmgren A
FASEB J; 2011 Jan; 25(1):370-81. PubMed ID: 20810785
[TBL] [Abstract][Full Text] [Related]
25. Thioredoxin reductase is required for the inactivation of tumor suppressor p53 and for apoptosis induced by endogenous electrophiles.
Cassidy PB; Edes K; Nelson CC; Parsawar K; Fitzpatrick FA; Moos PJ
Carcinogenesis; 2006 Dec; 27(12):2538-49. PubMed ID: 16777982
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of both thioredoxin reductase and glutathione reductase may contribute to the anticancer mechanism of TH-302.
Li S; Zhang J; Li J; Chen D; Matteucci M; Curd J; Duan JX
Biol Trace Elem Res; 2010 Sep; 136(3):294-301. PubMed ID: 19838642
[TBL] [Abstract][Full Text] [Related]
27. Human selenium-dependent thioredoxin reductase from HeLa cells: properties of forms with differing heparin affinities.
Gorlatov SN; Stadtman TC
Arch Biochem Biophys; 1999 Sep; 369(1):133-42. PubMed ID: 10462449
[TBL] [Abstract][Full Text] [Related]
28. Menadione inhibits thioredoxin reductase 1 via arylation at the Sec
Sun S; Xu W; Zhang Y; Yang Y; Ma Q; Xu J
Free Radic Biol Med; 2021 Aug; 172():482-489. PubMed ID: 34186208
[TBL] [Abstract][Full Text] [Related]
29. The mammalian cytosolic selenoenzyme thioredoxin reductase reduces ubiquinone. A novel mechanism for defense against oxidative stress.
Xia L; Nordman T; Olsson JM; Damdimopoulos A; Björkhem-Bergman L; Nalvarte I; Eriksson LC; Arnér ES; Spyrou G; Björnstedt M
J Biol Chem; 2003 Jan; 278(4):2141-6. PubMed ID: 12435734
[TBL] [Abstract][Full Text] [Related]
30. Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors.
Rackham O; Shearwood AM; Thyer R; McNamara E; Davies SM; Callus BA; Miranda-Vizuete A; Berners-Price SJ; Cheng Q; Arnér ES; Filipovska A
Free Radic Biol Med; 2011 Mar; 50(6):689-99. PubMed ID: 21172426
[TBL] [Abstract][Full Text] [Related]
31. Mechanism-based inactivation of thioredoxin reductase from Plasmodium falciparum by Mannich bases. Implication for cytotoxicity.
Davioud-Charvet E; McLeish MJ; Veine DM; Giegel D; Arscott LD; Andricopulo AD; Becker K; Müller S; Schirmer RH; Williams CH; Kenyon GL
Biochemistry; 2003 Nov; 42(45):13319-30. PubMed ID: 14609342
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of thioredoxin reductase by curcumin analogs.
Liu Z; Du ZY; Huang ZS; Lee KS; Gu LQ
Biosci Biotechnol Biochem; 2008 Aug; 72(8):2214-8. PubMed ID: 18685195
[TBL] [Abstract][Full Text] [Related]
33. Details in the catalytic mechanism of mammalian thioredoxin reductase 1 revealed using point mutations and juglone-coupled enzyme activities.
Xu J; Cheng Q; Arnér ES
Free Radic Biol Med; 2016 May; 94():110-20. PubMed ID: 26898501
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of Mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity.
Lu J; Papp LV; Fang J; Rodriguez-Nieto S; Zhivotovsky B; Holmgren A
Cancer Res; 2006 Apr; 66(8):4410-8. PubMed ID: 16618767
[TBL] [Abstract][Full Text] [Related]
35. On the potential of thioredoxin reductase inhibitors for cancer therapy.
Urig S; Becker K
Semin Cancer Biol; 2006 Dec; 16(6):452-65. PubMed ID: 17056271
[TBL] [Abstract][Full Text] [Related]
36. Thimerosal, a competitive thioredoxin reductase 1 (TrxR1) inhibitor discovered via high-throughput screening.
Ni Y; Luo Z; Lv Y; Ma S; Luo C; Du D
Biochem Biophys Res Commun; 2023 Apr; 650():117-122. PubMed ID: 36780763
[TBL] [Abstract][Full Text] [Related]
37. Pyrroloquinoline quinone modulates the kinetic parameters of the mammalian selenoprotein thioredoxin reductase 1 and is an inhibitor of glutathione reductase.
Xu J; Arnér ES
Biochem Pharmacol; 2012 Mar; 83(6):815-20. PubMed ID: 22226931
[TBL] [Abstract][Full Text] [Related]
38. Small molecule inhibitors of mammalian thioredoxin reductase.
Cai W; Zhang L; Song Y; Wang B; Zhang B; Cui X; Hu G; Liu Y; Wu J; Fang J
Free Radic Biol Med; 2012 Jan; 52(2):257-65. PubMed ID: 22064364
[TBL] [Abstract][Full Text] [Related]
39. Thioredoxin reductase inhibitors: a patent review.
Zhang B; Zhang J; Peng S; Liu R; Li X; Hou Y; Han X; Fang J
Expert Opin Ther Pat; 2017 May; 27(5):547-556. PubMed ID: 27977313
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of thioredoxin reductase by mansonone F analogues: Implications for anticancer activity.
Liu Z; Huang SL; Li MM; Huang ZS; Lee KS; Gu LQ
Chem Biol Interact; 2009 Jan; 177(1):48-57. PubMed ID: 18822278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
